22-35746475-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001349999.2(RBFOX2):c.1224C>A(p.Asp408Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000501 in 1,596,738 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000035 ( 0 hom. )
Consequence
RBFOX2
NM_001349999.2 missense, splice_region
NM_001349999.2 missense, splice_region
Scores
1
7
9
Splicing: ADA: 0.00006175
2
Clinical Significance
Conservation
PhyloP100: 0.612
Genes affected
RBFOX2 (HGNC:9906): (RNA binding fox-1 homolog 2) This gene is one of several human genes similar to the C. elegans gene Fox-1. This gene encodes an RNA binding protein that is thought to be a key regulator of alternative exon splicing in the nervous system and other cell types. The protein binds to a conserved UGCAUG element found downstream of many alternatively spliced exons and promotes inclusion of the alternative exon in mature transcripts. The protein also interacts with the estrogen receptor 1 transcription factor and regulates estrogen receptor 1 transcriptional activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBFOX2 | NM_001349999.2 | c.1224C>A | p.Asp408Glu | missense_variant, splice_region_variant | 12/14 | ENST00000695854.1 | NP_001336928.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBFOX2 | ENST00000695854.1 | c.1224C>A | p.Asp408Glu | missense_variant, splice_region_variant | 12/14 | NM_001349999.2 | ENSP00000512219.1 | |||
RBFOX2 | ENST00000438146.7 | c.1236C>A | p.Asp412Glu | missense_variant, splice_region_variant | 12/14 | 1 | ENSP00000413035.2 | |||
RBFOX2 | ENST00000449924.6 | c.1023C>A | p.Asp341Glu | missense_variant, splice_region_variant | 11/13 | 1 | ENSP00000391670.2 | |||
RBFOX2 | ENST00000414461.6 | c.983C>A | p.Thr328Lys | missense_variant, splice_region_variant | 10/12 | 1 | ENSP00000407855.2 | |||
RBFOX2 | ENST00000695805.1 | n.*517C>A | splice_region_variant, non_coding_transcript_exon_variant | 11/13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4207C>A | splice_region_variant, non_coding_transcript_exon_variant | 13/15 | ENSP00000512187.1 | |||||
RBFOX2 | ENST00000695805.1 | n.*517C>A | 3_prime_UTR_variant | 11/13 | ENSP00000512185.1 | |||||
RBFOX2 | ENST00000695807.1 | n.*4207C>A | 3_prime_UTR_variant | 13/15 | ENSP00000512187.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152172Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000346 AC: 5AN: 1444566Hom.: 0 Cov.: 30 AF XY: 0.00000417 AC XY: 3AN XY: 719076
GnomAD4 exome
AF:
AC:
5
AN:
1444566
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
719076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74342
GnomAD4 genome
AF:
AC:
3
AN:
152172
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.1236C>A (p.D412E) alteration is located in exon 12 (coding exon 12) of the RBFOX2 gene. This alteration results from a C to A substitution at nucleotide position 1236, causing the aspartic acid (D) at amino acid position 412 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D;D
Sift4G
Benign
T;T;T;T;T
Polyphen
D;P;D;P;D
Vest4
MutPred
0.48
.;.;Loss of phosphorylation at Y320 (P = 0.1101);.;.;
MVP
MPC
2.1
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at